Literature DB >> 10901958

Haemoptysis in patients with a normal chest radiograph: bronchoscopy-CT correlation.

S Tak1, G Ahluwalia, S K Sharma, S Mukhopadhya, R Guleria, J N Pande.   

Abstract

The exact role of fibre-optic bronchoscopy (FOB) and CT of the chest in the diagnosis of patients presenting with haemoptysis and a normal or non-localizing chest radiograph has not been clearly defined. A study was designed to evaluate 50 patients presenting with haemoptysis and a normal or non-localizing chest radiograph using FOB and high-resolution computed tomography (HRCT). A definitive diagnosis was established in 17 (34%) patients. The aetiologies included bronchiectasis (24%), bronchial adenoma (6%), tuberculosis (2%) and bronchitis (2%). The diagnosis was made by HRCT in 15 (30%) patients, while FOB was diagnostic in five (10%) patients. The diagnosis was made by HRCT and FOB in all patients with focal airway abnormalities. Therefore, HRCT effectively delineated abnormalities of both the central and peripheral airways. It is concluded that CT should be obtained prior to FOB in all patients presenting with haemoptysis and a normal or non-localizing chest radiograph.

Entities:  

Mesh:

Year:  1999        PMID: 10901958     DOI: 10.1046/j.1440-1673.1999.00712.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  3 in total

1.  Non-bronchial causes of haemoptysis: imaging and interventions.

Authors:  Manphool Singhal; Anupam Lal; Nidhi Prabhakar; Mukesh K Yadav; Rajesh Vijayvergiya; Digamber Behra; Niranjan Khandelwal
Journal:  Pol J Radiol       Date:  2020-06-30

2.  Is investigation of patients with haemoptysis and normal chest radiograph justified?

Authors:  M Thirumaran; R Sundar; I M Sutcliffe; D C Currie
Journal:  Thorax       Date:  2009-05-19       Impact factor: 9.139

3.  Bronchial artery embolization in life-threatening massive hemoptysis.

Authors:  Hossein Ghanaati; Ali Shakouri Rad; Kavous Firouznia; Amir Hossein Jalali
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.